financetom
Business
financetom
/
Business
/
Bio-Techne Signs Distribution Deal With MedSanTek to Expand Product Reach in Turkey
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bio-Techne Signs Distribution Deal With MedSanTek to Expand Product Reach in Turkey
Dec 12, 2024 7:26 AM

10:05 AM EST, 12/12/2024 (MT Newswires) -- Bio-Techne ( TECH ) said Thursday it has entered a distribution agreement with MedSanTek to extend its product availability in Turkey.

The agreement enables MedSanTek, a leading distributor of in vitro diagnostics and research products in Turkey and Azerbaijan, to distribute Bio-Techne's ( TECH ) brands, including R&D Systems, Novus, Tocris, ProteinSimple, Advanced Cell Diagnostics and Asuragen, the life sciences company said.

Price: 75.76, Change: -1.05, Percent Change: -1.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - BAKKAVOR GROUP PLC
Form 8.3 - BAKKAVOR GROUP PLC
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3 - Greencore Group plc
Form 8.3 - Greencore Group plc
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3 - Spectris plc
Form 8.3 - Spectris plc
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3 - DOWLAIS GROUP PLC
Form 8.3 - DOWLAIS GROUP PLC
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved